Psilocybin study for people with psychiatric symptoms
Treatments studied
Part of Mental health clinical trials.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one mental health symptom (like depression, anxiety, or others) that has caused problems in your daily life for the past 30 days.
- You can speak and understand English well enough to give informed consent.
- You must have a friend or family member who can drive you home after the dosing session, or agree to use study-provided transportation.
- You need to have a regular doctor who can be contacted to confirm it is safe for you to participate.
- You must be willing to avoid certain medications and substances before and during the study, and have stable psychological therapy or medications for at least a month before joining.
- If you could become pregnant, you must agree to use effective birth control and have negative pregnancy tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called psilocybin (a hallucinogen that can help with depression) combined with group therapy can improve symptoms of depression. It requires participants to have significant depression symptoms and a support person to drive them home after each session.
This study tests whether a combination of mindfulness training and a single dose of psilocybin can help reduce PTSD symptoms. It is for people with moderate-to-severe PTSD who are not on certain medications and do not have major health problems.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This study tests whether a medicine called psilocybin, combined with talk therapy, can help people with hard-to-treat depression and a substance use problem. It aims to see if this treatment can improve mood and reduce substance use.
This trial tests psilocybin (a compound from certain mushrooms) combined with a structured therapy to see if it helps people with depression linked to trauma. It focuses on how the treatment affects the connection between the gut and brain.
Hear when a new Transdiagnostic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.